Technical Analysis for ASRT - Assertio Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.36 1.49% 0.02
ASRT closed up 1.49 percent on Friday, September 13, 2019, on 86 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical ASRT trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 1.49%
1,2,3 Retracement Bearish Bearish Swing Setup -1.45%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.45%
Spinning Top Other -1.45%
Wide Bands Range Expansion -1.45%
Pocket Pivot Bullish Swing Setup -2.16%
Wide Bands Range Expansion -2.16%

Older signals for ASRT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution), Xartemis XR and Zipsor (diclofenac potassium). Its NUCYNTA ER (tapentadol extended release tablets) is a product for the management of pain severe enough to require daily long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults, and its NUCYNTA (tapentadol) is a product for the management of moderate to severe acute pain in adults. Its Gralise (gabapentin) is a once-daily product for the management of postherpetic neuralgia (PHN). Its Cambia (diclofenac potassium for oral solution) is a product for the acute treatment of migraine attacks.
Pharmaceutical Pain Organ Systems Chemical Compounds Organic Compounds Analgesics Migraine Treatment Of Migraine Diabetic Peripheral Neuropathy Diclofenac Postherpetic Neuralgia
Is ASRT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 6.24
52 Week Low 1.23
Average Volume 1,338,970
200-Day Moving Average 3.6664
50-Day Moving Average 2.272
20-Day Moving Average 1.4065
10-Day Moving Average 1.337
Average True Range 0.1463
ADX 44.37
+DI 12.1952
-DI 29.5353
Chandelier Exit (Long, 3 ATRs ) 1.2311
Chandelier Exit (Short, 3 ATRs ) 1.6689
Upper Bollinger Band 1.6106
Lower Bollinger Band 1.2024
Percent B (%b) 0.39
BandWidth 29.022396
MACD Line -0.2546
MACD Signal Line -0.3137
MACD Histogram 0.0591
Fundamentals Value
Market Cap 85.66 Million
Num Shares 63 Million
EPS -1.79
Price-to-Earnings (P/E) Ratio -0.76
Price-to-Sales 0.75
Price-to-Book 1.50
PEG Ratio 0.46
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.45
Resistance 3 (R3) 1.45 1.42 1.44
Resistance 2 (R2) 1.42 1.40 1.42 1.43
Resistance 1 (R1) 1.39 1.38 1.39 1.39 1.42
Pivot Point 1.36 1.36 1.36 1.36 1.36
Support 1 (S1) 1.33 1.34 1.33 1.33 1.30
Support 2 (S2) 1.30 1.32 1.30 1.29
Support 3 (S3) 1.27 1.30 1.29
Support 4 (S4) 1.27